Hideho Okada is a professor at the department of Neurological Surgery of the University of Pittsburgh, and co-leader of the Brain Tumor program at the University's Cancer Institute. For more than 10 years, he has focused his efforts on the development of immunotherapies for brain tumors. His work has resulted in the identification of new glioma associated antigens, enabling the launch of clinical trials with DC-based vaccines and polyIC as adjuvants
Neurological Surgery